<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="https://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="https://www.loc.gov/MARC21/slim https://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="https://www.loc.gov/MARC21/slim">

  <leader>01620nam a2200277   4500</leader>
  <controlfield tag="001">384318</controlfield>
  <datafield tag="010" ind1=" " ind2=" ">
    <subfield code="a">9291681229</subfield>
  </datafield>
  <datafield tag="090" ind1=" " ind2=" ">
    <subfield code="a">384318</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">20070531d2002       y0pory50      ba</subfield>
  </datafield>
  <datafield tag="101" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="200" ind1=" " ind2=" ">
    <subfield code="a">Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs</subfield>
    <subfield code="f">European Monitoring Centre for Drugs and Drug Addiction, EMCDDA</subfield>
  </datafield>
  <datafield tag="210" ind1=" " ind2=" ">
    <subfield code="a">Luxembourg</subfield>
    <subfield code="c">Office for Official Publications of the European Communities</subfield>
    <subfield code="d">2002</subfield>
  </datafield>
  <datafield tag="215" ind1=" " ind2=" ">
    <subfield code="a">92 p.</subfield>
    <subfield code="d">21 cm</subfield>
  </datafield>
  <datafield tag="330" ind1=" " ind2=" ">
    <subfield code="a">Foreword. Abbreviations. Introduction. report on the risk assessment of GBH in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risks of GHB. Public health risks of GHB - epidemiological evidence. References. Participants in the risk-assessment process.</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">PREVEN&#xC7;&#xC3;O DA TOXICODEPEND&#xCA;NCIA</subfield>
    <subfield code="9">103892</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">RELAT&#xD3;RIO</subfield>
    <subfield code="9">410454</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">DROGA SINT&#xC9;TICA</subfield>
    <subfield code="9">320915</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">COOPERA&#xC7;&#xC3;O INTERNACIONAL</subfield>
    <subfield code="9">229150</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">OEDT</subfield>
    <subfield code="9">321506</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">EMCDDA</subfield>
    <subfield code="9">324041</subfield>
  </datafield>
  <datafield tag="710" ind1=" " ind2=" ">
    <subfield code="a">EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION</subfield>
    <subfield code="9">351987</subfield>
  </datafield>
  <datafield tag="955" ind1=" " ind2=" ">
    <subfield code="x">Oferta</subfield>
  </datafield>
  <datafield tag="995" ind1=" " ind2=" ">
    <subfield code="1">0</subfield>
    <subfield code="4">PJ_19_000000000000000_D_89</subfield>
    <subfield code="5">2022-06-06</subfield>
    <subfield code="6">PJ28090</subfield>
    <subfield code="9">414210</subfield>
    <subfield code="a">PJ</subfield>
    <subfield code="c">PJ</subfield>
    <subfield code="f">PJ128090</subfield>
    <subfield code="k">PJ19.D.89</subfield>
    <subfield code="n">2022-06-06</subfield>
    <subfield code="o">0</subfield>
    <subfield code="r">MO</subfield>
    <subfield code="x">Oferta</subfield>
  </datafield>
</record>
